Next Article in Journal
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group
Next Article in Special Issue
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy
Previous Article in Journal
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
Previous Article in Special Issue
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer
 
 
Brief Report

Article Versions Notes

Curr. Oncol. 2021, 28(5), 4167-4173; https://doi.org/10.3390/curroncol28050353
Action Date Notes Link
article pdf uploaded. 15 October 2021 17:18 CEST Version of Record https://www.mdpi.com/1718-7729/28/5/353/pdf-vor
article pdf uploaded. 15 October 2021 19:15 CEST Updated version of record https://www.mdpi.com/1718-7729/28/5/353/pdf-vor
article xml file uploaded 20 October 2021 06:35 CEST Original file -
article xml uploaded. 20 October 2021 06:35 CEST Update https://www.mdpi.com/1718-7729/28/5/353/xml
article pdf uploaded. 20 October 2021 06:35 CEST Updated version of record https://www.mdpi.com/1718-7729/28/5/353/pdf
article html file updated 20 October 2021 06:36 CEST Original file -
article html file updated 20 October 2021 10:14 CEST Update -
article html file updated 30 July 2022 11:15 CEST Update https://www.mdpi.com/1718-7729/28/5/353/html
Back to TopTop